GFM
LFCR icon

GF Fund Management’s Lifecore Biomedical LFCR Stock Holding History

GF Fund Management’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.11K Buy
836
+100
+14% +$690 ﹤0.01% 615
2025
Q4 		$6.02K Buy
+736
New +$5.45K ﹤0.01% 613

Other funds holding LFCR

2L
22NW LP Seattle, Washington $146M AUM 29.83% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
LPAM
Legion Partners Asset Management Los Angeles, California $138M AUM 53.69% 1-Year Est. Return
GRIM
Greenhaven Road Investment Management Greenwich, Connecticut $145M AUM 13.76% 1-Year Est. Return
3C
325 Capital New York $274M AUM 49.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
GC
Grizzlyrock Capital Chicago, Illinois $126M AUM 11.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GF Fund Management's LFCR Position: Q1 2026 in Review

GF Fund Management increased its Lifecore Biomedical (LFCR) stake by 14% in Q1 2026, buying an estimated $690 and bringing the position to 836 shares worth $3.11K. The position accounts for ﹤0.01% of the portfolio, ranked #615.

GF Fund Management first reported a position in LFCR in Q4 2025 and has held it in 2 quarters since. The position peaked at $6.02K in Q4 2025. 105 funds tracked by Wall St. Rank hold LFCR as of Q1 2026.

  • GF Fund Management held 836 shares of Lifecore Biomedical worth $3.11K as of Q1 2026.
  • GF Fund Management bought 100 Lifecore Biomedical shares in Q1 2026, an estimated $690.
  • Lifecore Biomedical made up ﹤0.01% of GF Fund Management's portfolio in Q1 2026, its #615 holding.
  • GF Fund Management first reported a position in Lifecore Biomedical in Q4 2025 and has held it in 2 quarters since.
  • GF Fund Management's Lifecore Biomedical position peaked at $6.02K in Q4 2025.
  • 105 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.